A detailed history of Zeke Capital Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Zeke Capital Advisors, LLC holds 6,377 shares of EW stock, worth $432,105. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,377
Previous 5,354 19.11%
Holding current value
$432,105
Previous $442,000 7.47%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$68.3 - $87.44 $69,870 - $89,451
1,023 Added 19.11%
6,377 $475,000
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $906 - $1,180
-11 Reduced 0.21%
5,354 $442,000
Q2 2022

Aug 09, 2022

SELL
$86.5 - $128.27 $2,249 - $3,335
-26 Reduced 0.48%
5,365 $510,000
Q1 2022

May 13, 2022

BUY
$101.96 - $128.34 $549,666 - $691,880
5,391 New
5,391 $634,000
Q1 2020

Apr 24, 2020

SELL
$52.41 - $81.0 $84,956 - $131,301
-1,621 Closed
0 $0
Q4 2019

Jan 17, 2020

SELL
$71.7 - $82.09 $97,368 - $111,478
-1,358 Reduced 45.59%
1,621 $378,000
Q3 2019

Oct 18, 2019

SELL
$61.55 - $75.43 $23,019 - $28,210
-374 Reduced 11.15%
2,979 $655,000
Q2 2019

Jul 24, 2019

SELL
$55.74 - $64.41 $19,509 - $22,543
-350 Reduced 9.45%
3,353 $619,000
Q1 2019

Apr 29, 2019

SELL
$47.89 - $64.05 $23,418 - $31,320
-489 Reduced 11.67%
3,703 $708,000
Q4 2018

Feb 11, 2019

SELL
$46.41 - $56.94 $9,560 - $11,729
-206 Reduced 4.68%
4,192 $642,000
Q1 2018

May 03, 2018

BUY
$37.19 - $47.45 $93,570 - $119,384
2,516 Added 133.69%
4,398 $614,000
Q4 2017

Feb 14, 2018

SELL
$33.79 - $39.39 $15,509 - $18,080
-459 Reduced 19.61%
1,882 $212,000
Q3 2017

Nov 09, 2017

BUY
$36.29 - $38.83 $84,954 - $90,901
2,341
2,341 $256,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Zeke Capital Advisors, LLC Portfolio

Follow Zeke Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zeke Capital Advisors, LLC with notifications on news.